Eli Lilly’s weight loss and diabetes injection tirzepatide—the active ingredient in Zepbound and Mounjaro—could improve symptoms of heart failure in patients with obesity, the company said ...

If you buy through links on this page, we may earn a small commission. Here’s our process. Zepbound (tirzepatide) is an injectable drug for weight loss in those with obesity or those with ...

Robert Hart is a London-based Forbes senior reporter. Obese and overweight adults taking tirzepatide (the generic name for Zepbound and Mounjaro) lost more weight and lost it faster than adults ...

Eli Lilly’s obesity drug Zepbound cut the risk of complications and improved symptoms in patients with a common type of heart failure, making it the second GLP-1 drug to show positive results in ...

Eli Lilly's weight loss drug Zepbound showed benefits in patients with a common type of heart failure and obesity, according to late-stage trial data. The findings add to mounting evidence that ...

Eli Lilly & Co.’s blockbuster Zepbound improved the long-term health of patients with obesity-related heart failure in a study, illuminating the cardiovascular benefits of the weight-loss shot.